<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02366858</url>
  </required_header>
  <id_info>
    <org_study_id>510467</org_study_id>
    <nct_id>NCT02366858</nct_id>
  </id_info>
  <brief_title>Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures</brief_title>
  <official_title>Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Florida Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Florida Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesis is that a 22 gauge needle can yield core tissue, obviating the
      need to use the 19 gauge needle for core tissue procurement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion Criteria

        1. Age under 19 years

        2. Pregnant women will be excluded. This will be confirmed by self-report

      Exclusion Criteria

        1. Age under 19 years

        2. Pregnant women will be excluded. This will be confirmed by self-report
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    PI decision was made to discontinue the study
  </why_stopped>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>22 gauge needle</measure>
    <time_frame>72 hours</time_frame>
    <description>Compare the quality of core tissue specimens obtained between a 19G and 22G needle by evaluating the ability to perform molecular marker studies or immunohistochemistry studies between samples obtained.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>19 gauge</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 19 gauge needle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>22 gauge</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 22 gauge needle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>19 gauge</intervention_name>
    <description>Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 19 gauge needle</description>
    <arm_group_label>19 gauge</arm_group_label>
    <arm_group_label>22 gauge</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>22 gauge</intervention_name>
    <description>Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 22 gauge needle</description>
    <arm_group_label>22 gauge</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients who are referred to Florida Hospital Center for Interventional Endoscopy
             for a EUS FNA for core biopsy (19 gauge needle biopsy) who have needle dysfunction
             (This occurs in about 10% of patients)

        Exclusion Criteria:

          -  Age under 19 years

          -  Pregnant women will be excluded. This will be confirmed by self-report
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shyam Varadarajulu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Florida Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2014</study_first_submitted>
  <study_first_submitted_qc>February 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2015</study_first_posted>
  <last_update_submitted>February 13, 2017</last_update_submitted>
  <last_update_submitted_qc>February 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>19 gauge</keyword>
  <keyword>22 gauge</keyword>
  <keyword>core tissue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

